Marcos Burgos

Therapeutic outcome 3 years after switching of immunomodulatory therapies in patients with relapsing–remitting multiple sclerosis in Argentina

Adriana Carrá, P. Onaha, Geraldine Luetic et al. · European Journal of Neurology · 2008 · 62 citations

Pharmacy, Neurology, Pharmacotherapy +17

COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America

Ricardo Alonso, Berenice Silva, Orlando Garcea et al. · Multiple Sclerosis and Related Disorders · 2021 · 40 citations · Full text

Medicine, Internal Medicine, Neurology +7

Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM)

Juan Ignacio Rojas, Orlando Garcea, Liliana Patrucco et al. · Neurological Sciences · 2020 · 28 citations

Medicine, Neurology, Neuroscience +7

What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM)

Edgar Carnero Contentti, Pablo A. López, Juan Pablo Pettinicchi et al. · Multiple Sclerosis and Related Disorders · 2021 · 27 citations

Life Sciences, Neurology, Neuroscience +11

Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: Data from a nationwide registry in Argentina

Edgar Carnero Contentti, Pablo A. López, Juan Pablo Pettinicchi et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 2021 · 23 citations · Full text

Medicine, Neurology, Pharmacotherapy +14